$BLTH
AMERICAN BATTERY MATERIALS, INC.

2022 Q4 Form 10-Q Financial Statement

#000121390022074161 Filed on November 21, 2022

View on sec.gov

Income Statement

Concept 2022 Q4 2022 Q3 2021 Q3
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $313.1K $331.7K $83.25K
YoY Change 129.4% 298.49% 40.22%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $313.1K $331.7K $83.25K
YoY Change 129.4% 298.48% 40.22%
Operating Profit -$331.7K -$83.25K
YoY Change 298.47% 40.23%
Interest Expense -$57.19K -$175.1K -$1.483M
YoY Change -103.03% -88.19% 540.88%
% of Operating Profit
Other Income/Expense, Net $175.1K $0.00
YoY Change -100.0%
Pretax Income -$338.3K -$506.9K -$1.536M
YoY Change -119.53% -66.99% 448.12%
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings -$338.3K -$506.9K -$1.536M
YoY Change -119.53% -66.99% 448.12%
Net Earnings / Revenue
Basic Earnings Per Share $0.00 -$0.01
Diluted Earnings Per Share $0.00 $0.00 -$5.868K
COMMON SHARES
Basic Shares Outstanding 385.6M shares 385.6M shares 174.8M shares
Diluted Shares Outstanding 385.6M shares 174.8M shares

Balance Sheet

Concept 2022 Q4 2022 Q3 2021 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $42.58K $52.95K $5.660K
YoY Change 413.63% 835.51%
Cash & Equivalents $42.58K $52.95K $5.655K
Short-Term Investments
Other Short-Term Assets $62.72K $6.760K
YoY Change 3463.64% -13.22%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $105.3K $142.8K $12.42K
YoY Change 947.33% 1049.88% 59.44%
LONG-TERM ASSETS
Property, Plant & Equipment $17.50K
YoY Change -71.59%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $100.0K $100.0K
YoY Change 0.0%
Total Long-Term Assets $100.0K $100.0K $17.50K
YoY Change 0.0% 471.43% -71.59%
TOTAL ASSETS
Total Short-Term Assets $105.3K $142.8K $12.42K
Total Long-Term Assets $100.0K $100.0K $17.50K
Total Assets $205.3K $242.8K $29.92K
YoY Change 86.54% 711.55% -56.88%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $438.7K $386.9K $308.2K
YoY Change 44.66% 25.54% -2.98%
Accrued Expenses $482.9K $489.0K $2.353M
YoY Change 38.67% -79.22% 11.71%
Deferred Revenue
YoY Change
Short-Term Debt $357.0K $0.00 $0.00
YoY Change -100.0%
Long-Term Debt Due $357.0K $6.871M $5.283M
YoY Change -93.23% 30.07% 16.83%
Total Short-Term Liabilities $1.506M $9.714M $7.944M
YoY Change -81.24% 22.28% 6.39%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $470.0K $831.2K
YoY Change -100.0% -43.46% -30.21%
Other Long-Term Liabilities $0.00 $0.00 $2.212M
YoY Change -100.0% -100.0% 2371.09%
Total Long-Term Liabilities $470.0K $3.043M
YoY Change -84.56% 137.63%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.506M $9.714M $7.944M
Total Long-Term Liabilities $470.0K $3.043M
Total Liabilities $1.506M $10.18M $10.99M
YoY Change -83.55% -7.31% 25.6%
SHAREHOLDERS EQUITY
Retained Earnings -$17.85M -$17.52M
YoY Change 9.08%
Common Stock $3.246M $385.6K
YoY Change 866.58%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$1.300M -$9.941M -$10.96M
YoY Change
Total Liabilities & Shareholders Equity $205.3K $242.8K $29.92K
YoY Change 86.54% 711.55% -56.88%

Cashflow Statement

Concept 2022 Q4 2022 Q3 2021 Q3
OPERATING ACTIVITIES
Net Income -$338.3K -$506.9K -$1.536M
YoY Change -119.53% -66.99% 448.12%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$910.7K -$209.5K -$89.74K
YoY Change 456.6% 133.42% 1694.8%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00 $0.00
YoY Change -100.0%
Cash From Investing Activities $0.00 $0.00 $0.00
YoY Change -100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 945.0K 250.0K 95.40K
YoY Change 254.93% 162.05% 1808.0%
NET CHANGE
Cash From Operating Activities -910.7K -209.5K -89.74K
Cash From Investing Activities 0.000 0.000 0.000
Cash From Financing Activities 945.0K 250.0K 95.40K
Net Change In Cash 34.29K 40.53K 5.660K
YoY Change 1203.8% 616.08% 622323581321214300.0%
FREE CASH FLOW
Cash From Operating Activities -$910.7K -$209.5K -$89.74K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Local Phone Number
LocalPhoneNumber
998-7962
dei City Area Code
CityAreaCode
800
dei Entity Shell Company
EntityShellCompany
false
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-09-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
333-165972
dei Entity Registrant Name
EntityRegistrantName
BOXSCORE BRANDS, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
22-3956444
dei Entity Address Address Line1
EntityAddressAddressLine1
500 West Putnam Avenue
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 400
dei Entity Address City Or Town
EntityAddressCityOrTown
Greenwich
dei Entity Address State Or Province
EntityAddressStateOrProvince
CT
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
06830
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
385568143 shares
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
52953 usd
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
8291 usd
CY2022Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
89862 usd
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1763 usd
CY2022Q3 us-gaap Assets Current
AssetsCurrent
142815 usd
CY2021Q4 us-gaap Assets Current
AssetsCurrent
10054 usd
CY2022Q3 us-gaap Mineral Properties Net
MineralPropertiesNet
100000 usd
CY2021Q4 us-gaap Mineral Properties Net
MineralPropertiesNet
100000 usd
CY2022Q3 us-gaap Assets
Assets
242815 usd
CY2021Q4 us-gaap Assets
Assets
110054 usd
CY2022Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
386878 usd
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
303248 usd
CY2022Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
489044 usd
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
348217 usd
CY2022Q3 us-gaap Interest Payable Current
InterestPayableCurrent
2400376 usd
CY2021Q4 us-gaap Interest Payable Current
InterestPayableCurrent
2104964 usd
CY2022Q3 us-gaap Senior Notes Current
SeniorNotesCurrent
75000 usd
CY2021Q4 us-gaap Senior Notes Current
SeniorNotesCurrent
95804 usd
CY2022Q3 us-gaap Other Notes Payable Current
OtherNotesPayableCurrent
503269 usd
CY2021Q4 us-gaap Other Notes Payable Current
OtherNotesPayableCurrent
473269 usd
CY2022Q3 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
5822973 usd
CY2021Q4 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
4664624 usd
CY2022Q3 boxs Current Capital Lease Obligation
CurrentCapitalLeaseObligation
36254 usd
CY2021Q4 boxs Current Capital Lease Obligation
CurrentCapitalLeaseObligation
36254 usd
CY2022Q3 us-gaap Liabilities Current
LiabilitiesCurrent
9713794 usd
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
8026380 usd
CY2022Q3 us-gaap Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
470000 usd
CY2021Q4 us-gaap Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
915000 usd
CY2021Q4 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
211345 usd
CY2022Q3 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
470000 usd
CY2021Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
1126345 usd
CY2022Q3 us-gaap Liabilities
Liabilities
10183794 usd
CY2021Q4 us-gaap Liabilities
Liabilities
9152725 usd
CY2022Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2022Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
50000 shares
CY2022Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
50000 shares
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q3 us-gaap Preferred Stock Value
PreferredStockValue
5 usd
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
4500000000 shares
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
4500000000 shares
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
385568143 shares
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
385568143 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
335778778 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
335778778 shares
CY2022Q3 us-gaap Common Stock Value
CommonStockValue
385567 usd
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
335778 usd
CY2022Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
7190026 usd
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
6989540 usd
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-17516577 usd
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-16367989 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-9940979 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-9042671 usd
CY2022Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
242815 usd
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
110054 usd
CY2022Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
331735 usd
CY2021Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
83252 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
821995 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
256899 usd
CY2022Q3 us-gaap Operating Expenses
OperatingExpenses
331735 usd
CY2021Q3 us-gaap Operating Expenses
OperatingExpenses
83252 usd
us-gaap Operating Expenses
OperatingExpenses
821995 usd
us-gaap Operating Expenses
OperatingExpenses
256899 usd
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-331735 usd
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-83252 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-821995 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-256899 usd
CY2021Q3 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
1242201 usd
us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
-211345 usd
us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
-871388 usd
CY2021Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-30769 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-62095 usd
CY2022Q3 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
175133 usd
CY2021Q3 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
240921 usd
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
537938 usd
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
645880 usd
CY2022Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
175133 usd
CY2021Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1452353 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
326593 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-287603 usd
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-506868 usd
CY2021Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1535605 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1148588 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
30704 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-506868 usd
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-1535605 usd
us-gaap Net Income Loss
NetIncomeLoss
-1148588 usd
us-gaap Net Income Loss
NetIncomeLoss
30704 usd
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
385568143 shares
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
174843415 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
382019948 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
179188115 shares
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
385568143 shares
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
174843415 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
382019948 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
340825434 shares
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-11773386 usd
us-gaap Stock Issued During Period Value Conversion Of Units
StockIssuedDuringPeriodValueConversionOfUnits
780765 usd
boxs Fair Value Of Warrants
FairValueOfWarrants
4722 usd
us-gaap Net Income Loss
NetIncomeLoss
30704 usd
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
-10957195 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-9042671 usd
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
50000 usd
us-gaap Stock Issued During Period Value Conversion Of Units
StockIssuedDuringPeriodValueConversionOfUnits
189200 usd
boxs Fair Value Of Warrants
FairValueOfWarrants
11080 usd
us-gaap Net Income Loss
NetIncomeLoss
-1148588 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-9940979 usd
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
-9693485 usd
CY2021Q3 us-gaap Stock Issued During Period Value Conversion Of Units
StockIssuedDuringPeriodValueConversionOfUnits
270321 usd
CY2021Q3 boxs Fair Value Of Warrants
FairValueOfWarrants
1574 usd
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-1535605 usd
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
-10957195 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-9494666 usd
CY2022Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
50000 usd
CY2022Q3 boxs Fair Value Of Warrants
FairValueOfWarrants
10555 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-506868 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-9940979 usd
us-gaap Net Income Loss
NetIncomeLoss
-1148588 usd
us-gaap Net Income Loss
NetIncomeLoss
30704 usd
us-gaap Share Based Compensation
ShareBasedCompensation
11080 usd
us-gaap Share Based Compensation
ShareBasedCompensation
4722 usd
us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
62095 usd
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
211345 usd
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
871388 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
88099 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
2170 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
241124 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
33054 usd
us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
-475490 usd
us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
-638343 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-720338 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-228831 usd
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
590000 usd
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
615000 usd
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
200000 usd
us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
50000 usd
us-gaap Repayments Of Debt And Capital Lease Obligations
RepaymentsOfDebtAndCapitalLeaseObligations
82000 usd
us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
75000 usd
us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
297100 usd
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
25000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
765000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
210900 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
44662 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-17931 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
8291 usd
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
23586 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
52953 usd
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
5655 usd
boxs Accounts Payable And Accrued Expenses Exchanged For Convertible Note
AccountsPayableAndAccruedExpensesExchangedForConvertibleNote
62099 usd
boxs Convertible Notes Converted To Common Stock
ConvertibleNotesConvertedToCommonStock
48804 usd
boxs Convertible Notes Converted To Common Stock
ConvertibleNotesConvertedToCommonStock
429150 usd
boxs Accrued Interest Exchanged Into Convertible Notes
AccruedInterestExchangedIntoConvertibleNotes
140396 usd
boxs Accrued Interest Exchanged Into Convertible Notes
AccruedInterestExchangedIntoConvertibleNotes
351615 usd
us-gaap Notes Issued1
NotesIssued1
170000 usd
us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
57372 usd
us-gaap Nature Of Operations
NatureOfOperations
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span><b>Note 1 – Nature of the Business</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span>BoxScore Brands, Inc. (formerly U-Vend Inc.) (the “Company”) is a US based renewable energy company focused on the extraction, refinement and distribution of technical minerals in an environmentally responsible manner.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span>The Company formerly developed, marketed and distributed various self-serve electronic kiosks and mall/airport co-branded islands throughout North America. Due to the nationwide shutdown related to the COVID-19 pandemic, the Company spent a portion of 2020 restructuring and retiring certain corporate debt and obligations. The Company focused on implementing a new operational direction.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span>Through the corporate reorganization and repositioning process, the Company found itself with the unique opportunity to expand its management team and acquire mining claims that historically reported high levels of Lithium and other tech minerals. The Company hired and affiliated itself with industry veterans that bring decades of experience, credibility and relationships.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span>On November 5, 2021, the Company acquired the rights to 102 Federal Mining Claims located in the Lisbon Valley of Utah for $100,000. The acquisition was driven by historical mineral data from seven (7) existing wells with brine aquifer access. The independent third-party Technical Report indicated that further investment and development in the claims were warranted.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span>The Company has been moving forward with its strategy of employing advanced brine extractive technology methodologies and has been in talks with numerous extraction providers. Selective mineral extraction is clearly the most cost-effective and ESG friendly approach currently available. Technologies are being utilized that can extract the desired minerals and metals from the brine and then re-inject the brines back down into the aquafer. The prospective partners have been provided the analytical results from the technical reports, but will soon provide current results, analytical, Geotech modeling, aquifer modeling, recharge, flows, and depth.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span>The Company will also look to expand its holdings in the Lisbon Valley area with the acquisition of additional mineral claims and joint venture opportunities.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span>On July 21, 2022, the Board of Directors for the Company (the “Board”) received the Resignation of Mr. Andrew Boutsikakis from his positions as Chief Executive Officer and Director for the Company. There are no disputes or disagreements between Mr. Boutsikakis and the Company.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span>Pursuant to the Resignation of Mr. Boutsikakis, on July 26, 2022, the Board unanimously approved and appointed Mr. Sebastian Lux to the position of Interim Chief Executive Officer. On the same date, the Board unanimously voted to increase the number of Directors on the Board to five (5), and subsequently approved and appointed Dr. Adam Lipson as a Director and Mr. David Graber as a Director for the Company.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; ">On August 17, 2022, the Board of Directors unanimously voted to increase the number of Directors on the Board to seven (7). On the same date, the Board subsequently approved and appointed Mr. Justin Vorwerk as a Director, and Mr. Andrew Suckling as a Director for the Company.</p>
CY2021Q4 us-gaap Payments To Acquire Mining Assets
PaymentsToAcquireMiningAssets
100000 usd
CY2021Q3 us-gaap Accrued Liabilities Fair Value Disclosure
AccruedLiabilitiesFairValueDisclosure
26062 usd
boxs Gain On Capital Lease Settlement
GainOnCapitalLeaseSettlement
16074 usd
CY2021Q3 us-gaap Due To Other Related Parties Noncurrent
DueToOtherRelatedPartiesNoncurrent
62095 usd
us-gaap Use Of Estimates
UseOfEstimates
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span><span style="text-decoration:underline">Use of Estimates</span></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span>The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect amounts reported in the financial statements and accompanying notes. Actual results could differ from those estimates and be based on events different from those assumptions. Future events and their effects cannot be predicted with certainty; estimating, therefore, requires the exercise of judgment. Thus, accounting estimates change as new events occur, as more experience is acquired, or as additional information is obtained.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p>
boxs Weighted Average Remaining Contractual Term Exercised
WeightedAverageRemainingContractualTermExercised
CY2021Q4 us-gaap Payments For Purchase Of Other Assets1
PaymentsForPurchaseOfOtherAssets1
100000 usd
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
243000000 shares
CY2021 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
162000000 shares
us-gaap Debt Conversion Converted Instrument Shares Issued1
DebtConversionConvertedInstrumentSharesIssued1
26507105 shares
us-gaap Debt Instrument Convertible If Converted Value In Excess Of Principal
DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal
0 usd
CY2021Q4 us-gaap Debt Instrument Fee Amount
DebtInstrumentFeeAmount
25000 usd
CY2022Q3 boxs Interest Rate
InterestRate
0.15 pure
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
30704 usd
boxs Gain Loss On Change In Fair Value Of Derivatives
GainLossOnChangeInFairValueOfDerivatives
-871388 usd
us-gaap Interest Expense Long Term Debt
InterestExpenseLongTermDebt
645880 usd
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-194804 usd
boxs Weighted Average Number Of Share Outstanding Basic
WeightedAverageNumberOfShareOutstandingBasic
179188115 shares
boxs Effect Of Dilutive Shares
EffectOfDilutiveShares
161637319 shares
boxs Weighted Average Number Of Diluted Share Outstanding
WeightedAverageNumberOfDilutedShareOutstanding
340825434 shares
boxs Earnings Per Shares Basic
EarningsPerSharesBasic
0
boxs Earnings Per Shares Diluted
EarningsPerSharesDiluted
0
CY2019Q2 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
108572 usd
CY2019Q2 us-gaap Debt Instrument Term
DebtInstrumentTerm
P2Y
CY2019Q2 us-gaap Investment Interest Rate
InvestmentInterestRate
0.095 pure
CY2019Q2 boxs Cash Paid In Common Stock Percentage
CashPaidInCommonStockPercentage
0.15 pure
CY2019Q2 us-gaap Debt Instrument Convertible Conversion Price1
DebtInstrumentConvertibleConversionPrice1
0.07
CY2022Q3 us-gaap Debt Instrument Fee Amount
DebtInstrumentFeeAmount
108572 usd
CY2021Q4 us-gaap Fair Value Hedge Liabilities At Fair Value
FairValueHedgeLiabilitiesAtFairValue
211345 usd
boxs Forgave Aggregate Amount Of Accrued Expenses
ForgaveAggregateAmountOfAccruedExpenses
19959 usd
us-gaap Deferred Revenue Revenue Recognized1
DeferredRevenueRevenueRecognized1
0 usd
CY2020Q2 us-gaap Debt Instrument Term
DebtInstrumentTerm
P2Y
CY2020Q2 boxs Percentage Of Common Stock Paid
PercentageOfCommonStockPaid
0.15 pure
us-gaap Debt Instrument Term
DebtInstrumentTerm
P2Y
us-gaap Profit Loss
ProfitLoss
1148588 usd
CY2022Q3 boxs Accumulated Losses
AccumulatedLosses
17516577 usd
boxs Working Capital Deficit
WorkingCapitalDeficit
9570979 usd
CY2021 us-gaap Debt Instrument Periodic Payment Interest
DebtInstrumentPeriodicPaymentInterest
153686 usd
CY2021Q4 boxs Convertible Into Shares
ConvertibleIntoShares
98024360 shares
CY2021 boxs Shares Converted Into Common Stock Carrying Value
SharesConvertedIntoCommonStockCarryingValue
50000 usd
boxs Carrying Value
CarryingValue
50000 usd
boxs Common Stock Per Share
CommonStockPerShare
0.05
CY2017Q4 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
87043 usd
CY2020Q4 us-gaap Convertible Debt
ConvertibleDebt
108804 usd
CY2021Q4 us-gaap Investment Owned Balance Principal Amount
InvestmentOwnedBalancePrincipalAmount
88000 usd
CY2021 us-gaap Debt Conversion Converted Instrument Shares Issued1
DebtConversionConvertedInstrumentSharesIssued1
23157894 shares
CY2021 boxs Carrying Value
CarryingValue
20804 usd
CY2022Q3 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
20804 usd
us-gaap Debt Instrument Increase Accrued Interest
DebtInstrumentIncreaseAccruedInterest
79923 usd
CY2019 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
46584 usd
CY2019 boxs Additional Original Discount
AdditionalOriginalDiscount
3325 usd
boxs Promissory Note Outstanding
PromissoryNoteOutstanding
80000 usd
CY2021 boxs Outstanding Balance
OutstandingBalance
80000 usd
CY2019 boxs Principal Balance
PrincipalBalance
135000 usd
CY2019Q4 boxs Bearing Interest
BearingInterest
0.07 pure
CY2019Q4 us-gaap Investment Maturity Date
InvestmentMaturityDate
2019-08-31
CY2019 boxs Balance Outstanding
BalanceOutstanding
135000 usd
CY2022Q3 us-gaap Deposit Liabilities Accrued Interest
DepositLiabilitiesAccruedInterest
120000 usd
CY2020Q4 boxs Total Principal And Accrued Interest
TotalPrincipalAndAccruedInterest
118250 usd
CY2022Q3 us-gaap Derivative Fixed Interest Rate
DerivativeFixedInterestRate
0.02 pure
CY2020 boxs Total Principal And Accrued Interest
TotalPrincipalAndAccruedInterest
37712 usd
us-gaap Interest Paid
InterestPaid
9.5 usd
CY2022Q3 us-gaap Debt Instrument Interest Rate Effective Percentage
DebtInstrumentInterestRateEffectivePercentage
0.18 pure
CY2021Q4 us-gaap Investment Interest Rate
InvestmentInterestRate
0.15 pure
boxs Principal Outstanding Amount
PrincipalOutstandingAmount
16667 usd
CY2022Q3 us-gaap Debt Instrument Convertible Conversion Price1
DebtInstrumentConvertibleConversionPrice1
0.03
CY2022Q3 us-gaap Long Term Debt Term
LongTermDebtTerm
P1Y
CY2022Q3 boxs Cash Paid In Common Stock Percentage
CashPaidInCommonStockPercentage
0.15 pure
CY2022Q3 us-gaap Principal Amount Outstanding On Loans Securitized
PrincipalAmountOutstandingOnLoansSecuritized
590000 usd
CY2022Q3 boxs Aggregate Amount
AggregateAmount
256349 usd
CY2022Q3 us-gaap Debt Instrument Convertible Conversion Price1
DebtInstrumentConvertibleConversionPrice1
0.005
CY2022Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
5196243 usd
CY2022Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
1475000 usd
CY2022Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
200000 usd
CY2022Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
6871243 usd
CY2021Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
211345 usd
CY2020Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
3083255 usd
us-gaap Change In Unrealized Gain Loss On Fair Value Hedging Instruments1
ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1
211345 usd
us-gaap Change In Unrealized Gain Loss On Fair Value Hedging Instruments1
ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1
871388 usd
CY2021Q3 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
2211867 usd
CY2018 us-gaap Lease Expiration Date1
LeaseExpirationDate1
2023-12-31
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
1.89 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
0.0396 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0 pure
CY2022Q3 boxs Lessee Operating Leases Liability Payments Due Next Twelve Months
LesseeOperatingLeasesLiabilityPaymentsDueNextTwelveMonths
36692 usd
CY2022Q3 boxs Lessee Operating Leases Liability Payments Due
LesseeOperatingLeasesLiabilityPaymentsDue
36692 usd
CY2022Q3 boxs Less Amount Represented Interest
LessAmountRepresentedInterest
438 usd
CY2022Q3 boxs Present Value Of Minimum Lease Payments And Guaranteed Residual Value
PresentValueOfMinimumLeasePaymentsAndGuaranteedResidualValue
36254 usd
CY2022Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2022Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
50000 shares
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q3 us-gaap Excess Stock Shares Issued
ExcessStockSharesIssued
50000 shares
CY2022Q3 us-gaap Temporary Equity Par Or Stated Value Per Share
TemporaryEquityParOrStatedValuePerShare
0.001
CY2022Q3 us-gaap Temporary Equity Liquidation Preference Per Share
TemporaryEquityLiquidationPreferencePerShare
1
CY2022Q3 boxs Common Stock Vote Percentage
CommonStockVotePercentage
-0.60 pure
CY2022Q3 boxs Purchase Price
PurchasePrice
50000 usd
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
385568143 shares
CY2022Q3 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
105240424 shares
CY2020 us-gaap Debt Conversion Converted Instrument Warrants Or Options Issued1
DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1
3000000 shares
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
3.39 pure
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0135 pure
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
boxs Warrant Expense
WarrantExpense
525 usd
boxs Warrant Expense
WarrantExpense
4722 usd
boxs Warrant Expense Vesting
WarrantExpenseVesting
10555 usd
boxs Warrant Expense Vesting
WarrantExpenseVesting
0 usd
CY2017Q4 us-gaap Stock Issued During Period Shares Period Increase Decrease
StockIssuedDuringPeriodSharesPeriodIncreaseDecrease
10000000 shares
CY2017Q4 us-gaap Stock Issued During Period Shares Other
StockIssuedDuringPeriodSharesOther
15000000 shares
CY2022Q3 us-gaap Other Assets Current
OtherAssetsCurrent
usd
CY2021Q4 us-gaap Other Assets Current
OtherAssetsCurrent
usd
CY2022Q3 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
usd
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2022Q3 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
usd
CY2022Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
usd
us-gaap Repayments Of Debt And Capital Lease Obligations
RepaymentsOfDebtAndCapitalLeaseObligations
usd
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
usd
us-gaap Interest Paid Net
InterestPaidNet
usd
us-gaap Interest Paid Net
InterestPaidNet
usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
usd
boxs Accounts Payable And Accrued Expenses Exchanged For Convertible Note
AccountsPayableAndAccruedExpensesExchangedForConvertibleNote
usd
us-gaap Notes Issued1
NotesIssued1
usd
us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
usd
CY2022Q3 us-gaap Fair Value Hedge Liabilities At Fair Value
FairValueHedgeLiabilitiesAtFairValue
usd
CY2022Q3 boxs Unamortized Debt Discounts
UnamortizedDebtDiscounts
usd
CY2022Q3 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
usd
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
shares
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
boxs Weighted Average Remaining Contractual Term Granted
WeightedAverageRemainingContractualTermGranted
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
boxs Weighted Averages Remaining Contractual Term Cancelled Or Expired
WeightedAveragesRemainingContractualTermCancelledOrExpired
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
shares
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
CY2022Q3 boxs Weighted Average Remaining Contractual Term Outstanding Ending
WeightedAverageRemainingContractualTermOutstandingEnding
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
shares
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Entity Central Index Key
EntityCentralIndexKey
0001487718

Files In Submission

Name View Source Status
0001213900-22-074161-index-headers.html Edgar Link pending
0001213900-22-074161-index.html Edgar Link pending
0001213900-22-074161.txt Edgar Link pending
0001213900-22-074161-xbrl.zip Edgar Link pending
boxs-20220930.xsd Edgar Link pending
f10q0922ex31-1_boxscore.htm Edgar Link pending
f10q0922ex32-1_boxscore.htm Edgar Link pending
f10q0922_boxscore.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
boxs-20220930_def.xml Edgar Link unprocessable
boxs-20220930_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
boxs-20220930_lab.xml Edgar Link unprocessable
f10q0922_boxscore_htm.xml Edgar Link completed
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
boxs-20220930_cal.xml Edgar Link unprocessable